Anne Parker

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

Ronjon Chakraverty, Karl S. Peggs, Rajesh Chopra et al. · Blood · 2002 · 344 citations · Full text

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

Emma Morris, Kirsty Thomson, Charles Craddock et al. · Blood · 2004 · 288 citations · Full text

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Per Ljungman, KN Ward, Anne Parker et al. · Bone Marrow Transplantation · 2001 · 287 citations

Respiratory Virus Infections, Transplantation, Marrow Transplantation +6

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

Karl S. Peggs, Ann Hunter, Rajesh Chopra et al. · The Lancet · 2005 · 277 citations

Lymphoid Neoplasia, Transplantation, Immunology +8

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

Josè Antonio Pérez-Simón, Panagiotis Kottaridis, Rodrigo Martino et al. · Blood · 2002 · 243 citations · Full text